SCHEMBL6152713

SCHEMBL6152713

CN1C(=O)C2=C(c3cccc4ccccc34)N(C)C(=O)C2=C1c1cc(-c2cccc3ccccc23)cc(-c2cccc3ccccc23)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 2/20 0.40
ACMSD Q8TDX5 1/20 0.40
POLB P06746 1/20 0.40
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA9 Q16790 2/20 0.39
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALPL P05186 1/20 0.38
GAA P10253 1/20 0.38
PPARG P37231 5/20 0.37
PPARA Q07869 5/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
PPARD Q03181 1/20 0.37
EDNRB P24530 1/20 0.37
EDNRA P25101 1/20 0.37
PRKDC P78527 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6152442 0.89 POLB (0.47) POLBCA12CA1CA2CA9
SCHEMBL12394339 0.88 PPARG (0.37) MCL1ACMSDPOLBCA12CA1
SCHEMBL12394321 0.87 PIM1 (0.43) POLBHDAC8KDM4EALPLGAA
SCHEMBL12394330 0.87 POLB (0.41) MCL1ACMSDPOLBCA12CA1
SCHEMBL12394336 0.87 PPARG (0.44) MCL1ACMSDPOLBCA12CA1
SCHEMBL12394337 0.86 POLB (0.45) POLBCA12CA1CA2CA9
SCHEMBL12394329 0.85 PPARG (0.37) MCL1ACMSDPOLBCA12CA1
SCHEMBL12394328 0.84 PPARG (0.41) MCL1ACMSDPOLBCA12CA1
SCHEMBL2757065 0.84 POLB (0.41) POLBKDM4EALPLGAACYP2C9
SCHEMBL14620065 0.82 POLB (0.41) POLBKDM4EALPLGAACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1253151-B1 Pyrromethene metal complex and light emitting device composition and light emitting devices using the same TORAY INDUSTRIES (JP) 2005-01-12 EP disclosed
US-6805978-B2 COMPLEX CONTAINING DIKETOPYRROLO(3,4-C)PYRROLE COMPOUND TORAY INDUSTRIES, INC. (JP) 2004-10-19 US disclosed
US-20030082406-A1 Complex containing diketopyrrolo(3,4-c)pyrrole compound TORAY INDUSTRIES, INC. (JP) 2003-05-01 US disclosed
EP-1253151-A1 Pyrromethene metal complex and light emitting device composition and light emitting devices using the same TORAY INDUSTRIES, INC. (JP) 2002-10-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030082406-A1 Complex containing diketopyrrolo(3,4-c)pyrrole compound PPOX, CPNE4, TP53RK MCL1 4464/4885ACMSD 1060/4885POLB 2334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.